{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:11:42Z","timestamp":1787184702511,"version":"build-2736575974"},"reference-count":38,"publisher":"Japan Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej19-0307","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T22:03:27Z","timestamp":1575929007000},"page":"317-326","source":"Crossref","is-referenced-by-count":33,"title":["The proportion of peripheral blood Tregs among the CD4+ T cells of autoimmune thyroid disease patients: a meta-analysis"],"prefix":"10.1507","volume":"67","author":[{"given":"Ziyi","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqian","family":"He","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqian","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baosong","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyin","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Effraimidis G, Wiersinga WM (2014) Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol 170: R241\u2013R252.","DOI":"10.1530\/EJE-14-0047"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P (2015) Autoimmune thyroid disorders. Autoimmun Rev 14: 174\u2013180.","DOI":"10.1016\/j.autrev.2014.10.016"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3 McLeod DS, Cooper DS (2012) The incidence and prevalence of thyroid autoimmunity. Endocrine 42: 252\u2013265.","DOI":"10.1007\/s12020-012-9703-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Brent GA (2010) Environmental exposures and autoimmune thyroid disease. Thyroid 20: 755\u2013761.","DOI":"10.1089\/thy.2010.1636"},{"key":"5","unstructured":"5 Ai J, Leonhardt JM, Heymann WR (2003) Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic manifestations. J Am Acad Dermatol 48: 641\u2013659; quiz 660\u2013662."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Tanaka A, Sakaguchi S (2017) Regulatory T cells in cancer immunotherapy. Cell Res 27: 109\u2013118.","DOI":"10.1038\/cr.2016.151"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD, et al. (2007) Association of the interleukin-2 receptor alpha (IL-2Ralpha)\/CD25 gene region with Graves\u2019 disease using a multilocus test and tag SNPs. Clin Endocrinol 66: 508\u2013512.","DOI":"10.1111\/j.1365-2265.2007.02762.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ban Y, Tozaki T, Tobe T, Ban Y, Jacobson EM, et al. (2007) The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun 28: 201\u2013207.","DOI":"10.1016\/j.jaut.2007.02.016"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Yang X, Lun Y, Jiang H, Liu X, Duan Z, et al. (2018) SIRT1-regulated abnormal acetylation of FOXP3 induces regulatory T-cell function defect in Hashimoto\u2019s thyroiditis. Thyroid 28: 246\u2013256.","DOI":"10.1089\/thy.2017.0286"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Manolova I, Gerenova J, Ivanova M (2013) Serum levels of transforming growth factor-\u03b21 (TGF-\u03b21) in patients with systemic lupus erythematosus and Hashimoto\u2019s thyroiditis. Eur Cytokine Netw 24: 69\u201374.","DOI":"10.1684\/ecn.2013.0331"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11 Nakano A, Watanabe M, Iida T, Kuroda S, Matsuzuka F, et al. (2007) Apoptosis-induced decrease of intrathyroidal CD4(+) CD25(+) regulatory T cells in autoimmune thyroid diseases. Thyroid 17: 25\u201331.","DOI":"10.1089\/thy.2006.0231"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Afeltra A, Paggi A, Ferri GM, Amoroso A, Di Prima MA, et al. (1993) CD5+ B lymphocytes and CD4+ CD45RA+ T cells in Graves\u2019 disease. Endocr Res 19: 73\u201385.","DOI":"10.1080\/07435809309035409"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Roman-Gonzalez A, Moreno ME, Alfaro JM, Uribe F, Latorre-Sierra G, et al. (2009) Frequency and function of circulating invariant NKT cells in autoimmune diabetes mellitus and thyroid diseases in Colombian patients. Hum Immunol 70: 262\u2013268.","DOI":"10.1016\/j.humimm.2009.01.012"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Li C, Yuan J, Zhu YF, Yang XJ, Wang Q, et al. (2016) Imbalance of Th17\/Treg in different subtypes of autoimmune thyroid diseases. Cell Physiol Biochem 40: 245\u2013252.","DOI":"10.1159\/000452541"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Mao C, Wang S, Xiao Y, Xu J, Jiang Q, et al. (2011) Impairment of regulatory capacity of CD4+ CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves\u2019 disease. J Immunol 186: 4734\u20134743.","DOI":"10.4049\/jimmunol.0904135"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Glick AB, Wodzinski A, Fu P, Levine AD, Wald DN (2013) Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid 23: 871\u2013878.","DOI":"10.1089\/thy.2012.0514"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Matsuzawa K, Izawa S, Okura T, Fujii S, Matsumoto K, et al. (2016) Implications of FoxP3-positive and -negative CD4(+) CD25(+) T cells in Graves\u2019 ophthalmopathy. Endocr J 63: 755\u2013764.","DOI":"10.1507\/endocrj.EJ16-0108"},{"key":"18","unstructured":"18 Paggi A, Amoroso A, Ferri GM, Mariotti A, Pellegrino C, Afeltra A (1998) Methimazole treatment in Graves\u2019 disease: behaviour of CD5+ B lymphocytes and regulatory T cell subsets. Eur Rev Med Pharmacol Sci 2: 11\u201319."},{"key":"19","doi-asserted-by":"crossref","unstructured":"20 Klatka M, Grywalska E, Partyka M, Charytanowicz M, Kiszczak-Bochynska E, Rolinski J (2014) Th17 and Treg cells in adolescents with Graves\u2019 disease. Impact of treatment with methimazole on these cell subsets. Autoimmunity 47: 201\u2013211.","DOI":"10.3109\/08916934.2013.879862"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21 Liu Y, Tang X, Tian J, Zhu C, Peng H, et al. (2014) Th17\/Treg cells imbalance and GITRL profile in patients with Hashimoto\u2019s thyroiditis. Int J Mol Sci 15: 21674\u201321686.","DOI":"10.3390\/ijms151221674"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22 Xue H, Yu X, Ma L, Song S, Li Y, et al. (2015) The possible role of CD4<sup>+<\/sup>CD25(high)Foxp3<sup>+<\/sup>\/CD4<sup>+<\/sup>IL-17A<sup>+<\/sup> cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis. Endocrine 50: 665\u2013673.","DOI":"10.1007\/s12020-015-0569-y"},{"key":"22","doi-asserted-by":"publisher","unstructured":"23 Watanabe M, Yamamoto N, Maruoka H, Tamai H, Matsuzuka F, et al. (2002) Independent involvement of CD8+ CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto\u2019s disease. Thyroid 12: 801\u2013808.","DOI":"10.1089\/105072502760339370"},{"key":"23","doi-asserted-by":"publisher","unstructured":"24 Fountoulakis S, Vartholomatos G, Kolaitis N, Frillingos S, Philippou G, Tsatsoulis A (2008) HLA-DR expressing peripheral T regulatory cells in newly diagnosed patients with different forms of autoimmune thyroid disease. Thyroid 18: 1195\u20131200.","DOI":"10.1089\/thy.2008.0089"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25 Volp\u00e9 R (2001) The immunomodulatory effects of anti-thyroid drugs are mediated <i>via<\/i> actions on thyroid cells, affecting thyrocyte-immunocyte signalling: a review. Curr Pharm Des 7: 451\u2013460.","DOI":"10.2174\/1381612013397898"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26 Tian Y, Chen T, Wu Y, Yang L, Wang L, et al. (2017) Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17\/Treg balance in AMPK-dependent mechanisms. Cardiovasc Diabetol 16: 140.","DOI":"10.1186\/s12933-017-0623-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27 Wang Y, Zhou C, Gao H, Li C, Li D, et al. (2017) Therapeutic effect of Cryptotanshinone on experimental rheumatoid arthritis through downregulating p300 mediated-STAT3 acetylation. Biochem pharmacol 138: 119\u2013129.","DOI":"10.1016\/j.bcp.2017.05.006"},{"key":"27","unstructured":"28 Guo Y, Zynat J, Xing S, Xin L, Li S, et al. (2018) Immunological changes of T helper cells in flow cytometer-sorted CD4 T cells from patients with Hashimoto\u2019s thyroiditis. Exp Ther Med 15: 3596\u20133602."},{"key":"28","doi-asserted-by":"crossref","unstructured":"29 Dominguez-Villar M, Hafler DA (2018) Regulatory T cells in autoimmune disease. Nat Immunol 19: 665\u2013673.","DOI":"10.1038\/s41590-018-0120-4"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30 Deng C, Li W, Chen S, Li Y (2017) Meta-analysis of the changes of peripheral blood regulatory T cell to CD4 T cell ratio in patients with systemic sclerosis. Sci Rep 7: 43532.","DOI":"10.1038\/srep43532"},{"key":"30","unstructured":"31 D\u00edaz A, Santucci N, Bongiovanni B, D\u2019Attilio L, Massoni C, et al. (2015) Increased frequency of CD4+ CD25+ FoxP3+ T regulatory cells in pulmonary tuberculosis patients undergoing specific treatment and its relationship with their immune-endocrine profile. J Immunol Res 2015: 985302."},{"key":"31","doi-asserted-by":"crossref","unstructured":"32 Wang Y, Wu LP, Fu J, Lv HJ, Guan XY, et al. (2013) Hyperthyroid monkeys: a nonhuman primate model of experimental Graves\u2019 disease. J Endocrinol 219: 183\u2013193.","DOI":"10.1530\/JOE-13-0279"},{"key":"32","doi-asserted-by":"publisher","unstructured":"33 Saitoh O, Nagayama Y (2006) Regulation of Graves\u2019 hyperthyroidism with naturally occurring CD4+ CD25+ regulatory T cells in a mouse model. Endocrinology 147: 2417\u20132422.","DOI":"10.1210\/en.2005-1024"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34 Vitales-Noyola M, Serrano-Somavilla A, Mart\u00ednez-Hern\u00e1ndez R, Sampedro-Nu\u00f1ez M, Ramos-Levi AM, et al. (2018) Patients with autoimmune thyroiditis show diminished levels and defective suppressive function of Tr1 regulatory lymphocytes. J Clin Endocrinol Metab 103: 3359\u20133367.","DOI":"10.1210\/jc.2018-00498"},{"key":"34","doi-asserted-by":"crossref","unstructured":"36 Pellerin L, Jenks JA, B\u00e9gin P, Bacchetta R, Nadeau KC (2014) Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res 58: 358\u2013368.","DOI":"10.1007\/s12026-014-8512-5"},{"key":"35","doi-asserted-by":"crossref","unstructured":"37 Zheng L, Wang X, Xu L, Wang N, Cai P, et al. (2015) Foxp3 gene polymorphisms and haplotypes associate with susceptibility of Graves\u2019 disease in Chinese Han population. Int Immunopharmacol 25: 425\u2013431.","DOI":"10.1016\/j.intimp.2015.02.020"},{"key":"36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/cei.12557","volume":"180","author":"B Kristensen","year":"2015","unstructured":"38 Kristensen B, Heged\u00fcs L, Madsen HO, Smith TJ, Nielsen CH (2015) Altered balance between self-reactive T helper (Th)17 cells and Th10 cells and between full-length forkhead box protein 3 (FoxP3) and FoxP3 splice variants in Hashimoto\u2019s thyroiditis. Clin Exp Immunol 180: 58\u201369.","journal-title":"Clinical & Experimental Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"37","doi-asserted-by":"crossref","unstructured":"39 Zhang D, Qiu X, Li J, Zheng S, Li L, Zhao H (2019) MiR-23a-3p-regulated abnormal acetylation of FOXP3 induces regulatory T cell function defect in Graves\u2019 disease. Biol Chem 400: 639\u2013650.","DOI":"10.1515\/hsz-2018-0343"},{"key":"38","doi-asserted-by":"crossref","unstructured":"40 Esensten JH, Muller YD, Bluestone JA, Tang Q (2018) Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: the next frontier. J Allergy Clin Immunol 142: 1710\u20131718.","DOI":"10.1016\/j.jaci.2018.10.015"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/3\/67_EJ19-0307\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T09:49:19Z","timestamp":1722160159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/3\/67_EJ19-0307\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej19-0307","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}